Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Ask A Virologist: How Does GlaxoSmithKline's Potential Coronavirus Vaccine Work?

TheMotleyFool

0 0

Ask A Virologist: How Does GlaxoSmithKline's Potential Coronavirus Vaccine Work?

Pfizer (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) reported incredible efficacy data from a phase 3 trial for their mRNA coronavirus vaccine candidate. This news, paired with the equally impressive data from Moderna (NASDAQ: MRNA) about its candidate that takes a similar approach, inspired much hope around the world and injected optimism into the stock market.

We spoke with Dr. Angela Rasmussen, a virologist and Associate Research Scientist at Columbia Center for Infection and Immunity, about one of the companies working on a COVID-19 vaccine that hasn't been hogging the headlines: GlaxoSmithKline (NYSE: GSK).

Source Fool.com

Like: 0

GSK

Share